Chrome Extension
WeChat Mini Program
Use on ChatGLM

Time to treatment discontinuation of second-line fulvestrant monotherapy for HR+/HER2-metastatic breast cancer in the real-world setting

P. Luhn,C. O'Hear,T. G. Ton,T. Sanglier,A. Hsieh, D. Oliveri, J. Chuo, Y. Xiao,L. Emens

CANCER RESEARCH(2019)

Cited 0|Views1
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined